PODCAST · health
A New Frontier in the Co-Management of Thyroid Eye Disease
by Annenberg Center for Health Sciences
Thyroid eye disease, also known as Graves’ orbitopathy, is a potentially serious, progressive autoimmune disease that most often occurs in people with hyperthyroidism, ie, Graves’ disease. Kimberley Cockerham, MD, FACS, moderates this series of six, paired conversations between endocrinologist Terry J. Smith, MD, and eye specialists Wendy W. Lee, MD, and Raymond Douglas, MD, PhD, to explore current and emerging treatment options for thyroid eye disease. In these conversations, faculty review the current understanding of the burden and pathophysiology of thyroid eye disease—including treatment
-
6
Radiation, Surgery
The role for external beam radiation and orbital decompression in treating patients with thyroid eye disease Other surgical options for treating patients with thyroid eye disease
-
5
Clinical Trials Experience
Clinical data supporting the approval of teprotumumab How efficacy was assessed in the teprotumumab trials Emerging therapies for patients with thyroid eye disease
-
4
Treatment
The role of intervention in patient management Therapy selection for patients with thyroid eye disease Evaluating treatment responses
-
3
Patient Evaluation
How patients present with thyroid eye disease Differential diagnosis for thyroid eye disease How endocrinologists and ophthalmologists approach patient evaluation
-
2
Pathophysiology
Causes of thyroid eye disease Known risk factors in thyroid eye disease
-
1
Burden of Disease
Incidence and prevalence of thyroid eye disease The clinical implications of thyroid eye disease for patients The traditional course of thyroid eye disease
No matches for "" in this podcast's transcripts.
No topics indexed yet for this podcast.
Loading reviews...
ABOUT THIS SHOW
Thyroid eye disease, also known as Graves’ orbitopathy, is a potentially serious, progressive autoimmune disease that most often occurs in people with hyperthyroidism, ie, Graves’ disease. Kimberley Cockerham, MD, FACS, moderates this series of six, paired conversations between endocrinologist Terry J. Smith, MD, and eye specialists Wendy W. Lee, MD, and Raymond Douglas, MD, PhD, to explore current and emerging treatment options for thyroid eye disease. In these conversations, faculty review the current understanding of the burden and pathophysiology of thyroid eye disease—including treatment
HOSTED BY
Annenberg Center for Health Sciences
Loading similar podcasts...
URL copied to clipboard!